The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices. The ad is running on CNN and Fox in Washington, DC, and on Facebook and Twitter. The CREATES Act (S. 974/H.R. 2212) would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief. More than 40 organizations, including the AHA, last month urged House and Senate leaders to pass the legislation. 

Related News Articles

Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…